Aggrecan in Cardiovascular Development and Disease

Overview

Journal J Histochem Cytochem

Publisher Sage Publications

Specialty Biochemistry

Date 2020 Sep 2

PMID 32870742

Citations 26

Authors

Christopher D Koch

Chan Mi Lee

Suneel S Apte

Affiliations

Soon will be listed here.

Abstract

Aggrecan is a large proteoglycan that forms giant hydrated aggregates with hyaluronan in the extracellular matrix (ECM). The extraordinary resistance of these aggregates to compression explains their abundance in articular cartilage of joints where they ensure adequate load-bearing. In the brain, they provide mechanical buffering and contribute to formation of perineuronal nets, which regulate synaptic plasticity. Aggrecan is also present in cardiac jelly, developing heart valves, and blood vessels during cardiovascular development. Whereas aggrecan is essential for skeletal development, its function in the developing cardiovascular system remains to be fully elucidated. An excess of aggrecan was demonstrated in cardiovascular tissues in aortic aneurysms, atherosclerosis, vascular re-stenosis after injury, and varicose veins. It is a product of vascular smooth muscle and is likely to be an important component of pericellular matrix, where its levels are regulated by proteases. Aggrecan can contribute to specific biophysical and regulatory properties of cardiovascular ECM via the diverse interactions of its domains, and its accumulation is likely to have a significant role in developmental and disease pathways. Here, the established biological functions of aggrecan, its cardiovascular associations, and potential roles in cardiovascular development and disease are discussed.

Citing Articles

Soluble Proteoglycans and Proteoglycan Fragments as Biomarkers of Pathological Extracellular Matrix Remodeling.

Kemberi M, Minns A, Santamaria S Proteoglycan Res. 2024; 2(4):e70011.

PMID: 39600538 PMC: 11587194. DOI: 10.1002/pgr2.70011.

Isolation and tracing of matrix-producing notochordal and chondrocyte cells using ACAN-2A-mScarlet reporter human iPSC lines.

Tong X, Poramba-Liyanage D, van Hoolwerff M, Riemers F, Montilla-Rojo J, Warin J Sci Adv. 2024; 10(43):eadp3170.

PMID: 39441923 PMC: 11498221. DOI: 10.1126/sciadv.adp3170.

Protein glycosylation in cardiovascular health and disease.

Chatham J, Patel R Nat Rev Cardiol. 2024; 21(8):525-544.

PMID: 38499867 DOI: 10.1038/s41569-024-00998-z.

A machine learning algorithm for peripheral artery disease prognosis using biomarker data.

Li B, Shaikh F, Zamzam A, Syed M, Abdin R, Qadura M iScience. 2024; 27(3):109081.

PMID: 38361633 PMC: 10867451. DOI: 10.1016/j.isci.2024.109081.

Temporal Progression of Aortic Valve Pathogenesis in a Mouse Model of Osteogenesis Imperfecta.

Thatcher K, Mattern C, Chaparro D, Goveas V, McDermott M, Fulton J J Cardiovasc Dev Dis. 2023; 10(8).

PMID: 37623368 PMC: 10455328. DOI: 10.3390/jcdd10080355.

References

LANDAUER W . NANOMELIA, A LETHAL NUTATION OF THE FOWL. J Hered. 1965; 56:131-8. DOI: 10.1093/oxfordjournals.jhered.a107392. View

Arciniegas E, Neves C, Candelle D, Parada D . Differential versican isoforms and aggrecan expression in the chicken embryo aorta. Anat Rec A Discov Mol Cell Evol Biol. 2004; 279(1):592-600. DOI: 10.1002/ar.a.20042. View

Marzoll A, Melchior-Becker A, Cipollone F, Fischer J . Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?. J Cell Mol Med. 2009; 15(2):232-43. PMC: 3822791. DOI: 10.1111/j.1582-4934.2009.00986.x. View

Miller R, Ishihara S, Tran P, Golub S, Last K, Miller R . An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight. 2018; 3(6). PMC: 5926921. DOI: 10.1172/jci.insight.95704. View

Didangelos A, Yin X, Mandal K, Saje A, Smith A, Xu Q . Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics. 2011; 10(8):M111.008128. PMC: 3149094. DOI: 10.1074/mcp.M111.008128. View

Montero J, Giron B, Arrechedera H, Cheng Y, Scotting P, Chimal-Monroy J . Expression of Sox8, Sox9 and Sox10 in the developing valves and autonomic nerves of the embryonic heart. Mech Dev. 2002; 118(1-2):199-202. DOI: 10.1016/s0925-4773(02)00249-6. View

Nandadasa S, Nelson C, Apte S . ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation. Cell Rep. 2015; 11(10):1519-28. PMC: 4472575. DOI: 10.1016/j.celrep.2015.05.005. View

Krueger Jr R, Kurima K, Schwartz N . Completion of the mouse aggrecan gene structure and identification of the defect in the cmd-Bc mouse as a near complete deletion of the murine aggrecan gene. Mamm Genome. 1999; 10(12):1119-25. DOI: 10.1007/s003359901176. View

Watanabe H, Yamada Y . Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat Genet. 1999; 21(2):225-9. DOI: 10.1038/6016. View

10.

Jonsson-Rylander A, Nilsson T, Fritsche-Danielson R, Hammarstrom A, Behrendt M, Andersson J . Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol. 2004; 25(1):180-5. DOI: 10.1161/01.ATV.0000150045.27127.37. View

11.

Suna G, Wojakowski W, Lynch M, Barallobre-Barreiro J, Yin X, Mayr U . Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries. Circulation. 2017; 137(2):166-183. PMC: 5757669. DOI: 10.1161/CIRCULATIONAHA.116.023381. View

12.

Roccabianca S, Ateshian G, Humphrey J . Biomechanical roles of medial pooling of glycosaminoglycans in thoracic aortic dissection. Biomech Model Mechanobiol. 2013; 13(1):13-25. PMC: 3918738. DOI: 10.1007/s10237-013-0482-3. View

13.

Azeloglu E, Albro M, Thimmappa V, Ateshian G, Costa K . Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta. Am J Physiol Heart Circ Physiol. 2007; 294(3):H1197-205. DOI: 10.1152/ajpheart.01027.2007. View

14.

Kern C, Wessels A, McGarity J, Dixon L, Alston E, Argraves W . Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol. 2010; 29(4):304-16. PMC: 2862783. DOI: 10.1016/j.matbio.2010.01.005. View

15.

Humphrey J, Tellides G . Central artery stiffness and thoracic aortopathy. Am J Physiol Heart Circ Physiol. 2018; 316(1):H169-H182. PMC: 6880196. DOI: 10.1152/ajpheart.00205.2018. View

16.

Rittenhouse E, Dunn L, Cookingham J, Calo C, Spiegelman M, Dooher G . Cartilage matrix deficiency (cmd): a new autosomal recessive lethal mutation in the mouse. J Embryol Exp Morphol. 1978; 43:71-84. View

17.

Li Y, Klena N, Gabriel G, Liu X, Kim A, Lemke K . Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 2015; 521(7553):520-4. PMC: 4617540. DOI: 10.1038/nature14269. View

18.

Tompson S, Merriman B, Funari V, Fresquet M, Lachman R, Rimoin D . A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. Am J Hum Genet. 2008; 84(1):72-9. PMC: 2668039. DOI: 10.1016/j.ajhg.2008.12.001. View

19.

Robbins J, Vogel K . Regional expression of mRNA for proteoglycans and collagen in tendon. Eur J Cell Biol. 1994; 64(2):264-70. View

20.

Koo B, Coe D, Dixon L, Somerville R, Nelson C, Wang L . ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol. 2010; 176(3):1494-504. PMC: 2832168. DOI: 10.2353/ajpath.2010.090655. View